What do the new industry-led tuition deals mean for academia and postgraduate study?
The impending hike in university tuition fees in the UK is prompting companies to offer to shoulder the financial burden in order to attract top graduate talent. Pharma giant GlaxoSmithKline (GSK) followed the lead of accounting firm KPMG on Wednesday by announcing that it will reimburse tuition fees to all its UK recruits from September 2012. It’s an enticing deal – worth up to £27,000 for those taking a three-year degree – but what are the wider implications? Read more
Recent comments on this blog
African astronomy and how one student broke into the field
From Doctorate to Data Science: A very short guide
Work/life balance: New definitions